The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
MDMA (3, 4-methylenedioxymethamphetamine) or ‘Ecstasy’ is a widely used recreational drug that produces a state of heightened mood but also cardiovascular and vegetative side-effects. In animals, MDMA releases serotonin and, to a lesser extent, dopamine and norepinephrine. The release of serotonin can be blocked by serotonin uptake inhibitors such as citalopram. It is unknown to what extent this mechanism is also responsible for the physiological side-effects of MDMA seen in humans. We investigated the effect of citalopram pretreatment (40 mg i.v.) on vegetative and cardiovascular effects of MDMA (1.5 mg/kg p.o.) in a double-blind placebo-controlled study in 16 healthy volunteers. MDMA moderately increased blood pressure and heart rate, slightly elevated body temperature and produced a broad range of acute and shortterm side-effects. Citalopram reduced all these MDMA-induced physiological changes except for body temperature. These findings suggest that physiological effects of MDMA in humans are partially due to an interaction of MDMA with the serotonin carrier and a subsequent release of serotonin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00013-x · Cited by 448 · cited 8×
“Other commonly reported effects are bruxism (grinding of teeth), trismus (jaw clenching) and anorexia (Vollenweider et al., 1998).”
BackgroundMethodResultInfluentialSelf-citationMas, M., Farré, M., de la Torre, R., Roset, P. N., Segura, J. O., & Camí, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34877-3 · Cited by 362 · cited 2×
“Moderate increases in blood pressure and heart rate were also found in a pilot-study (Downing, 1986) and in placebocontrolled studies in healthy volunteers using comparable doses of MDMA (Vollenweider et al., 1998; Mas et al., 1999) or its analogue MDE (Gouzoulis et al.”
ResultLiechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248 · cited 3×
“Therefore, hyperthermia does not seem to be directly related to MDMAinduced serotonin release, but may reflect direct interaction of MDMA with postsynaptic receptors such as 5-HT2 receptors (Schmidt et al., 1990; Liechti et al., 2000b).”
BackgroundInfluentialSelf-citationLiechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00126-3 · Cited by 245 · cited 3×
“Therefore, hyperthermia does not seem to be directly related to MDMAinduced serotonin release, but may reflect direct interaction of MDMA with postsynaptic receptors such as 5-HT2 receptors (Schmidt et al., 1990; Liechti et al., 2000b).”
BackgroundInfluentialSelf-citation
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“Blockade of the serotonin transporter by pre-treatment with the SSRI citalopram, significantly attenuated the signature positive mood effects of MDMA (Liechti and Vollenweider, 2000, 2001) – presumably via preventing MDMA from interacting with the 5-HT transporter.”
MethodMithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
“…208 Scott Street, Mount Pleasant, SC 29464, USA Email: mmithoefer@mac.com To date, the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine are the only two drugs approved by the Food and Drug Administration (FDA) for this indication (Brady et al., 2000; Marshall et al., 2001).”
BackgroundToxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Capela, J. P., Carmo, H., Remião, F., Bastos, M. L., Meisel, A., & Carvalho, F. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8064-1 · Cited by 290
Metadata
- Authors
- Liechti, M. E., & Vollenweider, F. X.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2000-05
- Volume
- 14
- Issue
- 3
- Pages
- 269-274
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2121872553
- Cited by
- 144
- References
- 4
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers. https://app.cochat.ai/papers/10.1177/026988110001400313
- The paper
- Liechti, M. E., & Vollenweider, F. X. (2000). The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers. Journal of Psychopharmacology. https://doi.org/10.1177/026988110001400313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.